Walleye Capital LLC Hutchmed (China) LTD Transaction History

Walleye Capital LLC

  • $54.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$12.08 - $18.56 $213,344 - $327,788
-17,661 Reduced 55.92%
13,923 $233,000
Q4 2023

Feb 14, 2024
SELL
$16.25 - $20.23 $300,105 - $373,607
-18,468 Reduced 36.9%
31,584 $571,000
Q3 2023

Nov 21, 2023
BUY
$11.85 - $16.95 $593,116 - $848,381
50,052 New
50,052 $847,000

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email